Back to Journals » Comparative Effectiveness Research » Volume 7 » default

Comparative Effectiveness Research


Archive: Volume 7, 2017

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China

Li J, Ren HY, Zhang J, Dong P, Wang Y, Stevens AL, Han Y, Huang M

Comparative Effectiveness Research 2017, 7:1-9

Published Date: 23 January 2017